LATEST NEWS FROM LAMASSU BIOTECH

04/14/2026

FORMER FDA COMMISSIONER DR. STEPHEN HAHN JOINS LAMASSU BIOTECH BOARD OF DIRECTORS

Hahn will Bring Unparalleled Experience in Drug Development to Growing Biotech Firm (CLEVELAND, OH) – Stephen Hahn, MD, 24th Commissioner of Food and Drugs and the former chief medical executive...
READ THE ARTICLE
03/25/2026

Ohio State Launches Clinical Trial for Promising New Treatment for Acute Pancreatitis in Dogs

Study could transform care for a leading cause of hospitalizations in pets and people (COLUMBUS, OH) - Acute pancreatitis is a painful, life-threatening condition that affects an estimated 1.8 million...
READ THE ARTICLE
11/03/2025

SA53 MDM2 Inhibitor: Lamassu Biotech Reports Significant Progress and Favorable Safety Profile in Phase 1/2a Clinical Trial

 Novel SA53 MDM2 Inhibitor Therapy Has Potential to be a Breakthrough in Genetically-Targeted Cancer Treatment (CLEVELAND, OH) – Lamassu Biotech, a clinical-stage pharmaceutical company, today announced a significant clinical milestone...
READ THE ARTICLE
10/28/2025

LAMASSU BIOTECH CO-FOUNDERS DOCTORS RABI AND GABI HANNA NAMED NOTABLE LEADERS IN HEALTH CARE TECHNOLOGY BY CRAIN’S CLEVELAND BUSINESS

Brothers Recognized for Their Pioneering Work in Cancer Treatment (CLEVELAND, OH) – Drs. Rabi and Gabi Hanna, two brothers who immigrated to the United States, now making pioneering strides in...
READ THE ARTICLE
07/29/2025

LAMASSU PETS NAMES FORMER NOVARTIS, PIEDMONT ANIMAL HEALTH EXECUTIVE MICHAEL KELLY AS STRATEGIC ADVISOR

(DURHAM, NC) – Lamassu Pets, the veterinary division of Lamassu Biotech, has announced the appointment of veteran animal health industry executive Michael Kelly to its Advisory Board. Widely respected in the animal health pharmaceutical sector, Kelly brings more...
READ THE ARTICLE
06/03/2025

SIGNIFICANT NIH GRANT WILL HELP LAMASSU BIOTECH ADVANCE LIFE-SAVING PANCREATITIS TREATMENT FOR DOGS

New ‘One Health’ Grant Could Help Man’s Best Friend with Groundbreaking Researchfor Presently Untreatable Condition, Provide Key Data for Human Treatment (CLEVELAND, OH) – Momentum continues to build for Lamassu...
READ THE ARTICLE
05/16/2025

LAMASSU BIOTECH COLLABORATES WITH THE OHIO STATE UNIVERSITY TO STUDY NEW THERAPY FOR MAN AND MAN’S BEST FRIEND

Pioneering Research Will Help Drive Dual-Purpose Treatment for Life-Threatening Conditions in Both Humans and Man’s Best Friend (CLEVELAND, OH) – Man’s best friend may soon benefit from a new treatment,...
READ THE ARTICLE
02/07/2025

LAMASSU BIOTECH SET TO ATTEND LEAP 2025

International Conference in Saudi Arabia An Opportunity to Highlight Synergy BetweenTechnology and Medicine (CLEVELAND, OH) — Lamassu Biotech, a pioneering biotechnology company dedicated to developing breakthrough treatments for challenging diseases,...
READ THE ARTICLE
05/16/2024

LAMASSU BIOTECH WELCOMES DR. SAMIR JOHNA AS A CLINICAL ADVISOR

Esteemed Surgeon and Researcher Brings Decades of Experience to Drive Innovation in Biopharmaceuticals (CLEVELAND, OH) - Lamassu BioTech is thrilled to announce the addition of Dr. Samir Johna, MD, MACM,...
READ THE ARTICLE
05/16/2024

INNOVATIVE CANCER RESEARCH FIRM LAMASSU BIOTECH ANNOUNCES NEW CORPORATE OFFICES IN CLEVELAND

Lamassu Recently Earned Prestigious NIH Grant and Won FDA Approval to Trial Potentially Transformative Treatment for Metastatic Cancers (CLEVELAND, OH) – One of the pharmaceutical industry’s most leading-edge companies, Lamassu...
READ THE ARTICLE
04/11/2024

POSSIBLE NEW HOPE FOR METASTATIC CANCER PATIENTS: FDA GRANTS APPROVAL FOR CLINICAL TRIALS OF LAMASSU’S GROUNDBREAKING CANCER TREATMENT PROTOCOL

(CLEVELAND, OH) - More hope for successfully combating some of the deadliest cancers. Lamassu Biotech is proud to announce its pioneering effort to combat locally advanced metastatic p53 wild-type tumors...
READ THE ARTICLE
03/12/2024

LAMASSU AWARDED NIH GRANT FOR BREAKTHROUGH CANCER TREATMENT

Promising New Therapy for Sarcomas Could Reduce Reliance on Surgery, Chemotherapy and other Invasive and Toxic Treatments (CLEVELAND, OH) - Lamassu Bio Inc., a cutting-edge biotech company dedicated to innovative...
READ THE ARTICLE
04/20/2021

LAMASSU PHARMA ANNOUNCES DEVELOPMENT OF NEW PANCREATITIS TREATMENT THAT ADVANCES UNDERSTANDING OF FATTY ACIDS’ ROLE IN COVID-19

(DURHAM, NC) - Despite being known as "good" fat, excess unsaturated fatty acids may prove deadly for patients who develop, pancreatitis, COVID-19 and other acute illnesses. A new Mayo Clinic study...
READ THE ARTICLE

MEDIA COVERAGE

LAMASSU BIOTECH IN THE NEWS

See recent coverage about Lamassu Biotech's innovative cancer research and treatment.

Read More